2024-07-18 17:34:23 ET
Summary
- Hims & Hers is dedicated to telehealth and provides healthcare services remotely. It has an asset-light business model that has had extraordinary growth.
- The company began its growth by attacking markets sometimes overlooked by traditional medicine, such as dermatology or mental health.
- According to my valuation model, the stock could triple if it grows 35% annually in the coming years and reaches EBITDA margins of 25%. In my opinion, it's realistic.
Investment Thesis
Hims & Hers Health, Inc. ( HIMS ) is a stock that has had an extraordinary performance of 130% YTD thanks to the high growth it has had....
Read the full article on Seeking Alpha
For further details see:
Hims & Hers: The Thesis Goes Far Beyond GLP-1